OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Platelet Transfusion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,261 reports · 52 co-occurring drugs

As of the last recalculation, Platelet Transfusion appears in 1,261 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is VENETOCLAX (PRR 148.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Venetoclax386148.7149.6
Mesna Injection3469.870.1
Mesna3468.568.8
Dimenhydrinate3454.154.3
Azacitidine For5552.152.3
Micafungin Sodium2243.643.7
Polyethylene Glycol2742.042.2
Azacitidine6638.738.8
Tranexamic Acid1935.835.9
Eculizumab10233.633.7
Posaconazole Delayed-Release2132.132.1
Posaconazole2728.028.1
Vincristine Sulfate4425.625.7
Filgrastim5223.823.8
Busulfan2021.321.3
Pegaspargase1520.520.5
Temozolomide2419.119.2
Epoprostenol1316.616.6
Eltrombopag Olamine2216.016.0
Ifosfamide2015.615.6
Ursosiol1815.515.5
Cytarabine5315.215.2
Ganciclovir914.614.6
Ursodiol1914.614.6
Piperacillin Sodium,Tazobactam Sodium2314.614.6
Alteplase1314.414.4
Ganciclovir Sodium914.114.1
Daspone813.613.6
Dapsone Gel, 5%813.613.6
Axicabtagene Ciloleucel813.513.5
Romiplostim1213.313.3
Doxorubicin Hydrochloride2512.912.9
Tobramycin Solution912.412.5
Dapsone812.412.5
Ondansetron7712.312.3
Ondansetron Tablets7712.312.3
Tobramycin Sulfate912.112.1
Ondansetron Hydrochloride8211.711.7
Piperacillin And Tazobactam911.711.7
Niraparib1511.311.3
Heparin Sodium910.910.9
Thiotepa610.410.4
Hydroxyurea1310.210.2
Valacyclovir249.79.7
Prochlorperazine169.69.6
Bosentan268.78.7
Etoposide358.18.1
Doxorubicin387.27.2
Dasatinib167.27.2
Tolvaptan66.86.8
Obinutuzumab66.06.0
Selinexor35.75.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.